Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shandong Ruifeng Chemical Co., Ltd. (300243.SZ)
Zibo, CN
Shandong Ruifeng Chemical Co., Ltd. is a Chinese manufacturer and distributor specializing in chemical additives, with a primary focus on products designed for polyvinyl chloride (PVC) applications. The company offers a comprehensive range of chemical solutions, including various impact modifiers (such as acrylic, MBS, PC/ABS, ABS high rubber powder, and ASA high rubber powder), an assortment of PVC processing aids (including acrylic, lubricating, and LS resin types), and PVC lubricants. Beyond these, their product line also encompasses chlorinated polyethylene, PC/ABS resins, epichlorohydrin, and poly butylene adipate-co-terephthalate. While primarily serving the domestic Chinese market, Shandong Ruifeng Chemical also maintains a significant international presence, exporting its goods to key regions like Europe and the United States, as well as to customers throughout South, Southeast, and East Asia. Established in 1994, the company is headquartered in Zibo, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.16% | -11.75% | +6.86% | +50.44% | +70.90% | +80.73% | +84.99% | +117.92% | +38.81% | +43.35% | +200.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-1.6% Q1'26: +10.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+30.0% ★ Q1'26: +300.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.0% Q1'26: +0.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.9% Q1'26: +6.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.2% Q1'26: +6.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+5.7% Q1'26: -4.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.06× Q1'26: 6.73× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
804.85M
est: 890.00M (-9.6%)
|
873.51M
est: 903.00M (-3.3%)
|
1.10B
est: 985.00M (+11.2%)
|
1.45B
est: 1.08B (+34.3%)
|
1.86B
est: 1.65B (+12.7%)
|
2.59B
est.
|
1.83B
est: 3.50B (-47.7%)
|
1.78B
est: 3.50B (-49.3%)
|
2.00B
est: 903.00M (+121.6%)
|
1.97B
est: 985.00M (+99.9%)
|
985.00M
985.00M – 985.00M
+0.0% YoY
|
1.08B
1.08B – 1.08B
+9.2% YoY
|
1.65B
1.65B – 1.65B
+53.3% YoY
|
2.59B
2.59B – 2.59B
+56.9% YoY
|
3.50B
3.50B – 3.50B
+35.4% YoY
|
| EBITDA |
104.39M
est: 82.44M (+26.6%)
|
102.78M
est: 83.64M (+22.9%)
|
82.98M
est: 91.23M (-9.0%)
|
151.47M
est: 99.66M (+52.0%)
|
168.98M
est: 152.79M (+10.6%)
|
239.80M
est.
|
147.84M
est: 324.63M (-54.5%)
|
171.40M
est: 324.63M (-47.2%)
|
167.95M
est: 79.43M (+111.4%)
|
172.69M
est: 86.64M (+99.3%)
|
86.64M
86.64M – 86.64M
+0.0% YoY
|
94.65M
94.65M – 94.65M
+9.2% YoY
|
145.10M
145.10M – 145.10M
+53.3% YoY
|
227.73M
227.73M – 227.73M
+56.9% YoY
|
308.29M
308.29M – 308.29M
+35.4% YoY
|
| EBIT |
79.84M
est: 54.49M (+46.5%)
|
69.77M
est: 55.28M (+26.2%)
|
49.84M
est: 60.30M (-17.3%)
|
119.68M
est: 65.87M (+81.7%)
|
128.30M
est: 100.99M (+27.0%)
|
158.49M
est.
|
94.56M
est: 214.56M (-55.9%)
|
113.58M
est: 214.56M (-47.1%)
|
75.11M
est: 47.21M (+59.1%)
|
77.29M
est: 51.50M (+50.1%)
|
51.50M
51.50M – 51.50M
+0.0% YoY
|
56.26M
56.26M – 56.26M
+9.2% YoY
|
86.25M
86.25M – 86.25M
+53.3% YoY
|
135.36M
135.36M – 135.36M
+56.9% YoY
|
183.25M
183.25M – 183.25M
+35.4% YoY
|
| Net Income |
47.31M
est: 66.93M (-29.3%)
|
14.52M
est: 45.53M (-68.1%)
|
30.62M
est: 59.19M (-48.3%)
|
90.19M
est: 72.85M (+23.8%)
|
92.87M
est: 175.30M (-47.0%)
|
330.56M
est.
|
61.14M
est: 543.42M (-88.7%)
|
85.29M
est: 543.42M (-84.3%)
|
22.08M
est: 42.42M (-48.0%)
|
30.33M
est: 55.15M (-45.0%)
|
55.15M
55.15M – 55.15M
+0.0% YoY
|
67.88M
67.88M – 67.88M
+23.1% YoY
|
163.33M
163.33M – 163.33M
+140.6% YoY
|
307.99M
307.99M – 307.99M
+88.6% YoY
|
506.32M
506.32M – 506.32M
+64.4% YoY
|
| SGA |
116.98M
est: 68.91M (+69.8%)
|
129.42M
est: 69.92M (+85.1%)
|
120.03M
est: 76.27M (+57.4%)
|
178.41M
est: 83.32M (+114.1%)
|
182.22M
est: 127.73M (+42.7%)
|
200.46M
est.
|
209.92M
est: 271.38M (-22.6%)
|
187.34M
est: 271.38M (-31.0%)
|
183.23M
est: 84.58M (+116.6%)
|
115.39M
est: 92.26M (+25.1%)
|
92.26M
92.26M – 92.26M
+0.0% YoY
|
100.79M
100.79M – 100.79M
+9.2% YoY
|
154.52M
154.52M – 154.52M
+53.3% YoY
|
242.50M
242.50M – 242.50M
+56.9% YoY
|
328.29M
328.29M – 328.29M
+35.4% YoY
|
| EPS |
0.21
est: 0.27 (-21.4%)
|
0.06
est: 0.18 (-64.8%)
|
0.14
est: 0.24 (-40.8%)
|
0.40
est: 0.29 (+37.5%)
|
0.40
est: 0.70 (-42.9%)
|
1.32
est.
|
0.26
est: 2.17 (-88.0%)
|
0.36
est: 2.17 (-83.4%)
|
0.10
est: 0.18 (-45.0%)
|
0.13
est: 0.24 (-45.0%)
|
0.24
0.24 – 0.24
+0.0% YoY
|
0.29
0.29 – 0.29
+23.1% YoY
|
0.70
0.70 – 0.70
+140.6% YoY
|
1.32
1.32 – 1.32
+88.6% YoY
|
2.17
2.17 – 2.17
+64.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chunxin Liu | GM & Director | — | male |
| Hai Zhou | Deputy General Manager | — | male |
| Jian Wang | Deputy GM & Director | — | male |
| Ying Jie Xu | Accounting Supervisor | — | — |
| Yueling Xu | Financial Director | — | female |
| Zhigang Song | Deputy GM & Director | — | male |
| Ziyang Zhao | Secretary of the Board | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 300243.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
